Cathie Wood Intellia Therapeutics, Inc. Put Options Transaction History
Ark Investment Management LLC
- $9.28 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NTLA
# of Institutions
339Shares Held
98.3MCall Options Held
784KPut Options Held
713K-
Vanguard Group Inc Valley Forge, PA10.8MShares$128 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$53.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$45.4 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA3.78MShares$45.2 Million0.01% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $908M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...